Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06870617 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70)

Study acronym: PACE-70
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 24, 2026 (before its estimated October 1, 2026 completion). Its status may not reflect the trial's current state.
Trial flagged as At Risk
Primary completion moved at least 3 months later Jul 1, 2026 → Oct 1, 2026
See other at-risk trials from Abramson Cancer Center at Penn Medicine

Record History

  1. Enrollment closed, study ongoing Eligibility criteria expanded, about 11 words · Site details revised at 3 of 3 sites · Publications: details revised at 7 of 7 entries Show 3 more changesShow less
    • Eligibility criteria expanded, about 11 words
    • Site details revised at 3 of 3 sites
    • Publications: details revised at 7 of 7 entries
  2. Primary completion pushed from Jul 1, 2026 to Oct 1, 2026v5
  3. Site details revised at 3 of 3 sitesv4
  4. Trial status: Not Yet Recruiting to Recruiting Site details revised at 3 of 3 sitesv3 Show 1 more changeShow less
    • Site details revised at 3 of 3 sites
  5. Start date: Apr 1, 2025 to Jul 1, 2025 Primary completion date: Apr 1, 2026 to Jul 1, 2026 · Completion date: Jul 1, 2026 to Oct 1, 2026v2 Show 2 more changesShow less
    • Primary completion date: Apr 1, 2026 to Jul 1, 2026
    • Completion date: Jul 1, 2026 to Oct 1, 2026
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The use of a geriatric assessment to inform oncologic care for older persons with cancer is an evidence-based practice that improves patient-clinician communication, reduces treatment-related toxicity, and is recommended by national guidelines. However, the implementation of a geriatric assessment can be time-consuming and burdensome, leading to suboptimal use in clinical practice. Developed and endorsed by the American Society for Clinical Oncology (ASCO), the Practical Geriatric Assessment (PGA) is designed to improve clinical usability and adoption, but its implementation in real-world settings has not been evaluated. The PACE-70 study aims to evaluate PGA implementation and resultant chemotherapy dose modification among older adults with advanced cancer treated in a community setting. An exploratory aim will evaluate how the PGA, body composition (via abdominal computed tomography scan) and step count monitoring (via FitBit) correlate with chemotherapy toxicity and other clinical outcomes.
Trial Details
NCT Number NCT06870617
Lead Sponsor Abramson Cancer Center at Penn Medicine
Collaborators: Bristol-Myers Squibb
Conditions Geriatric Assessment, Advanced Cancer, Toxicity
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov